Manifold Creator
Stetson Thacker
@StetsonThacker
Markets by Stetson Thacker
Will fam-trastuzumab deruxtecan be the next pan-tumor approval?
$3K5 tradersResolved
97%
Will a TIGIT targeting agent receive FDA approval in any solid tumor indication before 2024?
$3594 tradersResolved
4%
Will Illumina be subject to M&A before end of 2025
$2615 tradersResolved
5%
Will Mustang Bio's MB-106 Receive RMAT Designation from FDA in 2024
$1001 tradersResolved
90%